Financials
Financial year 2025
BSB PHARMA from Ganshoren, company number BE0792204443, closed financial year 2025 with a result of € 9,660 after tax. For that financial year BSB PHARMA recorded a gross margin of € 51,324 and equity of € 79,924. Compared with financial year 2024, the result moved from € 31,567 to € 9,660. The company is profitable. The buffer is growing. A strong own buffer against the debts. The most recent annual accounts were filed with the National Bank of Belgium on April 6, 2026.
€ 79,924
▲ 14% vs 2024
Assets minus debts, by the books. What is left if everything were sold and paid today.
€ 9,660
▼ 69% vs 2024
Profit after tax over the fiscal year.
€ 110,921
▲ 35% vs 2024
Cash and bank balances on the last day of the fiscal year.
Stays in the company
No dividend for 2025. Retained profit grew to € 78,624.
People and assets in 2025
≈ 1
No payroll staff. One director, so that person most likely runs the business.
€ 75
▼ 72% vs 2024
Book value of vehicles, furniture and equipment.
Debts at end 2025
None
No bank loans on the last day of the fiscal year.
€ 7,502
▼ 57% vs 2024
Taxes, VAT and social contributions still to pay.
Want to see how much further we take a dossier in the Pro version? Open the free De Lijn example and give feedback →
| 2023 | 2024 | 2025 | Change 2024 → 2025 | |
|---|---|---|---|---|
| Gross margin | € 54,412 | € 44,132 | € 51,324 | ▲ 16% |
| Profit after taxes | € 38,996 | € 31,567 | € 9,660 | ▼ 69% |
| Equity | € 39,496 | € 70,264 | € 79,924 | ▲ 14% |
| Total debts | € 24,934 | € 19,130 | € 39,004 | ▲ 104% |
| Cash | € 61,886 | € 82,453 | € 110,921 | ▲ 35% |
| Retained profit | € 38,196 | € 68,964 | € 78,624 | ▲ 14% |
| Dividend | € 800 | € 800 | € 0 | ▼ 100% |
| Balance sheet total | € 64,430 | € 89,393 | € 118,927 | ▲ 33% |
Key figures of BSB PHARMA, fiscal years 2023 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 30 April 2027.
What happened to BSB PHARMA?
What happened at BSB PHARMA in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:
- New annual accounts for financial year 2025: profit of € 9,660 (▼ 69% vs 2024). Source: NBB ↗
- New establishment in Vorst. KBO
- Bassem Ben Salem became a director. NBB
- Start of the company according to the CBE. KBO
In short
From € 38,996 profit in 2023 to € 9,660 profit in 2025.
Paid € 30,382 in corporate taxes since 2023.
Best year ever: 2023, with € 38,996 profit.
Paid out € 1,600 in dividends to the owners in total.
A new publication or filing at BSB PHARMA? We notify you, reason included.
Follow BSB PHARMADatabakkes Pro
Know what changes at your customers, suppliers and competitors. Without reading an annual account.
- Follow them in one folder Every company in your folder gets this full dossier: household book, all fiscal years, benchmark against companies of the same size.
- We alert you, with the reason New annual account, Official Gazette publication or status change: you get what changed and where it says so.
- In bulk too, and in ChatGPT and Claude Upload your customer list and get the warning signs back per company. Or ask in your own AI assistant, with this register as the source.
Databakkes Pro is being built. Sign up now and you are first in line for an invitation, with a month to try without a credit card.
De Lijn 8 June 2026 New annual account 2025
filed on 8 June 2026
What was left
€ 20 k ▼ 91%
Money in the bank
€ 178 k ▼ 98%
Open the dossier →
NMBS 8 June 2026 New annual account 2025 What was left ▼ 80%
bpost 18 May 2026 New annual account 2025 What was left from loss to profit
Management
Directors
According to the 2025 annual accounts
Bassem Ben Salem
Director
since 2022
Establishments
Establishment units
Physical locations of this company
Georges Simpsonstraat 47
1083 Ganshoren
Halvemaanstraat 86
1190 Vorst
Active since 7 October 2022
Who else lives here?
A building full of entrepreneurs or one very busy letterbox? Another 1 companies are registered at this address.
All companies at this address →What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.
Details
- Company number
- 0792.204.443
- VAT number
- BE 0792.204.443
- Registered office
- Georges Simpsonstraat 47, 1083 Ganshoren
- Names & denominations
- BSB PHARMA
- Enterprise type
- Rechtspersoon
- Legal form
- Private limited company
- Legal situation
- Normale toestand
- Start date
- 7 October 2022
- Peppol
- Active · Active since 14 Nov 2025
- Contact
- [email protected]
- Activities · NACE
Detailhandel in farmaceutische producten
Overige zakelijke dienstverlening, neg